Supply Chain News

    Top 10 Pharma Supply Chain Trends for 2023: Part Two

    June 20, 2023

    In part two of this trends article, we will continue with the last five trends shaping the pharmaceutical supply chain and manufacturing industry in 2023. 6. New Modalities Will Require Innovation Drug modalities represent different types of drugs based on their composition, action and therapeutic Full Article

    Nippon Express Europe exhibits for the first time at LogiPharma 2023

    June 15, 2023

    Nippon Express Europe GmbH (President: Shinichi Kakiyama; hereinafter "NX Europe"), a Group company of NIPPON EXPRESS HOLDINGS, INC. (President: Mitsuru Saito), exhibited for the first time at "LogiPharma2023" held in Lyon, France from Tuesday, April 25 to Thursday, April 27. LogiPharma2023 is one of the Full Article

    Top 10 Pharma Supply Chain Trends for 2023: Part One

    June 5, 2023

    The pharmaceutical industry is constantly evolving, and one of the most critical areas of transformation is in the supply chain. The importance of a well-functioning supply chain has never been more evident than in recent years. A pandemic, geopolitical conflict, increased costs and uncertain availability Full Article

    How Route Optimization Benefits the Pharmaceutical Industry?

    May 25, 2023

    The timely transportation of lifesaving drugs is detrimental to the pharmaceutical industry’s success. Pharma companies work on clinical trials and advanced research that requires drug delivery and storage options. Even the slightest mistake during the logistics process may seriously delay the delivery and impact both Full Article
    Nippon Express

    Nippon Express Holdings submits letter of commitment to obtain Science Based Targets (SBTi) certification

    May 16, 2023

    NIPPON EXPRESS HOLDINGS, INC. (President: Mitsuru Saito), on May 16 submitted a letter of commitment to the Science Based Targets initiative (SBTi)1, an organization that certifies Science Based Targets (SBT)2, a set of greenhouse gas emission reduction targets set by the Paris Agreement. The Nippon Full Article
<--
Drug Distributor

Privacy Policy | Sitemap